ArticleCell reports2021

Pharmacological Wnt ligand inhibition overcomes key tumor-mediated resistance pathways to anti-PD-1 immunotherapy.

Nicholas C DeVito et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.